Evidence map›Paper›PMID 23897684›Full record

ReviewComprehensive Physiology2013

Bile acid metabolism and signaling.

John Y L Chiang

Registry-linked trialAbstract readReview
In one paragraph

Review in Comprehensive Physiology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07120828 (The Role of CYP8B1 Polymorphisms in Modulating the Biochemical Pathways Affected by SGLT2 Inhibitors in T2DM and Obesity), which is not on this map. Cited by 824 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
824citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07120828 phase4completedstarted 2025, after this paper: background citation

The Role of CYP8B1 Polymorphisms in Modulating the Biochemical Pathways Affected by SGLT2 Inhibitors in T2DM and Obesity

Ran2025Enrolled260Registered outcomes18Posted comparisons0ConditionsObese Diabetics, Obese Patients (BMI ≥ 30 kg/m²), Type 2 DiabetesArmsDapagliflozin (DAPA), Empagliflozin (oral), Metfomin
Open the trial in the graph
3 · Its place in the literature

Who cites it

824 citing papers in PubMed, 2 syntheses or guidelines pooled it, 1,388 citations in OpenAlex.

  1. Pooled it
  2. Pharmacological Mechanisms of Bile Acids Targeting the Farnesoid X Receptor.International journal of molecular sciences · 2024
    Pooled it
  3. Trial
  4. Virulence · 2026
    Article
  5. Review
  6. Bile acid signaling in health and disease.Molecular biomedicine · 2026
    Review
  7. Review
  8. Review
  9. Bile Acid Metabolism as a Unifying Readout for Diet, Microbiome Function, and Gastrointestinal Disease.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review

764 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

John Y L ChiangNortheast Ohio Medical University, Rootstown, Ohio, USA. Jchiang@neomed.edu
Northeast Ohio Medical University · US

Funding

MOLECULAR BIOLOGY OF BILE ACID SYNTHESISR01DK044442 · NIDDK · NORTHEAST OHIO MEDICAL UNIVERSITY · PI FERRELL, JESSICA MARIE · 1994 to 2022
$5.9M
Regulation of Bile Acid Synthesis by Nuclear ReceptorsR37DK058379 · NIDDK · NORTHEAST OHIO MEDICAL UNIVERSITY · PI CHIANG, JOHN Y. L. · 2011 to 2020
$3.6M
NIDDK NIH HHS R01 DK044442NIDDK NIH HHS R01DK44442NIDDK NIH HHS R37 DK058379NIDDK NIH HHS R37DK58379
6 · The paper itself

Abstract

Bile acids are important physiological agents for intestinal nutrient absorption and biliary secretion of lipids, toxic metabolites, and xenobiotics. Bile acids also are signaling molecules and metabolic regulators that activate nuclear receptors and G protein-coupled receptor (GPCR) signaling to regulate hepatic lipid, glucose, and energy homeostasis and maintain metabolic homeostasis. Conversion of cholesterol to bile acids is critical for maintaining cholesterol homeostasis and preventing accumulation of cholesterol, triglycerides, and toxic metabolites, and injury in the liver and other organs. Enterohepatic circulation of bile acids from the liver to intestine and back to the liver plays a central role in nutrient absorption and distribution, and metabolic regulation and homeostasis. This physiological process is regulated by a complex membrane transport system in the liver and intestine regulated by nuclear receptors. Toxic bile acids may cause inflammation, apoptosis, and cell death. On the other hand, bile acid-activated nuclear and GPCR signaling protects against inflammation in liver, intestine, and macrophages. Disorders in bile acid metabolism cause cholestatic liver diseases, dyslipidemia, fatty liver diseases, cardiovascular diseases, and diabetes. Bile acids, bile acid derivatives, and bile acid sequestrants are therapeutic agents for treating chronic liver diseases, obesity, and diabetes in humans.

Indexed as

AnimalsBile Acids and SaltsBiliary Tract DiseasesCholesterolEnterohepatic CirculationFeedback, PhysiologicalHomeostasisHumansInflammationLiverReceptors, Cytoplasmic and NuclearReceptors, G-Protein-CoupledSignal TransductionBile Acids and SaltsCholesterolReceptors, Cytoplasmic and NuclearReceptors, G-Protein-Coupled

Identifiers

PMID23897684
PMCPMC4422175
OpenAlexW2147259528

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.